detalle del documento
IDENTIFICACIÓN

oai:arXiv.org:2404.15335

Tema
Electrical Engineering and Systems... Computer Science - Machine Learnin...
Autor
Rashnu, Alireza Salimi-Badr, Armin
Categoría

Computer Science

Año

2024

fecha de cotización

1/5/2024

Palabras clave
graph parkinson disease
Métrico

Resumen

Efficient early diagnosis is paramount in addressing the complexities of Parkinson's disease because timely intervention can substantially mitigate symptom progression and improve patient outcomes.

In this paper, we present a pioneering deep learning architecture tailored for the binary classification of subjects, utilizing gait cycle datasets to facilitate early detection of Parkinson's disease.

Our model harnesses the power of 1D-Convolutional Neural Networks (CNN), Gated Recurrent Units (GRU), and Graph Neural Network (GNN) layers, synergistically capturing temporal dynamics and spatial relationships within the data.

In this work, 16 wearable sensors located at the end of subjects' shoes for measuring the vertical Ground Reaction Force (vGRF) are considered as the vertices of a graph, their adjacencies are modelled as edges of this graph, and finally, the measured data of each sensor is considered as the feature vector of its corresponding vertex.

Therefore, The GNN layers can extract the relations among these sensors by learning proper representations.

Regarding the dynamic nature of these measurements, GRU and CNN are used to analyze them spatially and temporally and map them to an embedding space.

Remarkably, our proposed model achieves exceptional performance metrics, boasting accuracy, precision, recall, and F1 score values of 99.51%, 99.57%, 99.71%, and 99.64%, respectively.

Rashnu, Alireza,Salimi-Badr, Armin, 2024, Integrative Deep Learning Framework for Parkinson's Disease Early Detection using Gait Cycle Data Measured by Wearable Sensors: A CNN-GRU-GNN Approach

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes
human papillomavirus cervical cancer screening self-sampling screening cervical cancer 1% uptake rate website acceptability online face-to-face participants